logo-loader
AIM:FARN

Faron Pharmaceuticals Ltd

Market:
AIM
Market Cap:
£198.43 m
Price
424.00 GBX
Change
-0.24%
52 weeks high
595.00
52 weeks low
79.00

In brief

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Deep dive We explore the investor case for growth companies

Snapshot

  • Focuses on Clevengen and Traumakine
  • Clevengen in studies for several types of cancer
  • Traumakine being tested as a treatment for coronavirus in three trials